The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Standard MM.4.10 (formerly TX.3.5.2) All prescriptions or medication orders are reviewed for appropriateness. A pharmacist must review all medication orders before dispensing a medication ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...

Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...

The clinic’s service area covers Minnesota’s southern central region, including Blue Earth, Brown, Faribault, Le Sueur, ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

High blood pressure silently damages vital organs without obvious symptoms, earning its reputation as a "silent killer." While millions receive prescriptions ...

The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...